| Literature DB >> 33948241 |
Shokoufeh Khalatbari1, Dianne Jazdzyk1, Janine Capsouras1, Brad Downey1, Eli Samuels1, Cathie Spino1,2.
Abstract
INTRODUCTION: Access to qualified biostatisticians to provide input on research design and statistical considerations is critical for high-quality clinical and translational research. At diverse health science institutions, like the University of Michigan (U-M), biostatistical collaborators are scattered across the campus. This model can isolate applied statisticians, analysts, and epidemiologists from each other, which may negatively affect their career development and job satisfaction, and inhibits access to optimal biostatistical support for researchers. Furthermore, in the era of modern, complex translational research, it is imperative to elevate biostatistical expertise by offering innovative training.Entities:
Keywords: Applied Biostatistical Sciences Network; Michigan Institute for Clinical and Health Research (MICHR); collaboration; consultation; translational research
Year: 2020 PMID: 33948241 PMCID: PMC8057411 DOI: 10.1017/cts.2020.506
Source DB: PubMed Journal: J Clin Transl Sci ISSN: 2059-8661
Fig. 1.Steps taken by the project team to establish the Applied Biostatistical Sciences (ABS) Network.
Fig. 2.Membership numbers 2018 through 2019. ABS, Applied Biostatistical Sciences.
Applied Biostatistical Sciences (ABS) network lectures/meetings for research community
| Year/Quarter | Event |
|---|---|
| 2018/1 | Lecture: Comparing and communicating adaptive designs for a dose-ranging study |
| 2018/2 | Member-only meeting: Missing data parts I and II – concepts, approaches, and imputation methods |
| 2018/3 | Lecture: Statistics and data science communication: tips and tricks for a new model of engagement |
| 2018/4 | Member-only meetings: Managing research partnerships parts I and II – statisticians are from Mars, clinicians are from Venus |
| 2019/1 | Lecture: Biomarker-driven clinical trial designs |
| 2019/2 | Member-only meeting: Statistical tools for healthcare policy and outcomes research |
| 2019/3 | Member-only meeting: Panel discussion on the role of statisticians versus data scientists |
| 2019/4 |
Lecture: Clinical trial data monitoring committees: the basics and some controversies Member-only meeting: Panel discussion: expectations of being a statistician member of Data and Safety Monitoring Boards (DSMBs) of clinical trials, best practices for statisticians who report to DSMBs, and issues and controversies that arise during the monitoring of ongoing trials |
| 2020/1 | Lecture: Sequential, multiple assignment, randomized trial clinical trial design for tailored treatment guidelines |